Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 6/20 | 0.53 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 4/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23798574 | 0.94 | FAAH (0.61) | CASP2FAAHDNM1NAAACNR1 | |
| SCHEMBL26301627 | 0.86 | FAAH (0.59) | CASP2FAAHDNM1NAAAMEN1 | |
| SCHEMBL14576902 | 0.84 | CASP2 (0.64) | CASP2FAAHDNM1NAAAMEN1 | |
| SCHEMBL25083401 | 0.83 | MEN1 (0.62) | CASP2FAAHDNM1NAAAMEN1 | |
| SCHEMBL16085238 | 0.82 | FAAH (0.66) | CASP2FAAHDNM1NAAAEPHX2 | |
| SCHEMBL19477959 | 0.82 | CASP2 (0.69) | CASP2FAAHDNM1NAAAMEN1 | |
| SCHEMBL26886295 | 0.82 | FAAH (0.66) | CASP2FAAHDNM1NAAAEPHX2 | |
| SCHEMBL726152 | 0.82 | CASP2 (0.68) | CASP2FAAHDNM1NAAAMEN1 | |
| SCHEMBL14576780 | 0.82 | CASP2 (0.68) | CASP2FAAHDNM1NAAAMEN1 | |
| SCHEMBL8558665 | 0.82 | MEN1 (0.61) | CASP2FAAHNAAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022262789-A1 | ANTITUMOR COMPOUND AND USE THEREOF | 明慧医药（杭州）有限公司 | 2022-12-22 | — | — | WO | disclosed |